Will Removing Rebates Really Lower Drug List Prices?
dc.contributor.author | Tran, Stephanie | |
dc.date | 2022-08-11T08:08:07.000 | |
dc.date.accessioned | 2022-08-23T15:43:02Z | |
dc.date.available | 2022-08-23T15:43:02Z | |
dc.date.issued | 2018-12-13 | |
dc.date.submitted | 2019-03-07 | |
dc.identifier.doi | 10.13028/cjft-w740 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/26995 | |
dc.description | <p>Blog post to Commonwealth Medicine's website - <a href="https://commed.umassmed.edu/blog/2018/12/13/will-removing-rebates-really-lower-drug-list-prices" target="_blank" title="blog post">view blog post online</a></p> | |
dc.description.abstract | The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for incentives to lower drug list prices, including removing rebates. Our clinical consultant Stephanie Tran continues our pharmacy blog series with an assessment of this potential change & its impacts. | |
dc.language.iso | en_US | |
dc.rights | © 2018 University of Massachusetts Medical School | |
dc.subject | rebates | |
dc.subject | drug prices | |
dc.subject | Department of Health and Human Services | |
dc.subject | Food and Drug Administration | |
dc.subject | price increases | |
dc.subject | generic competition | |
dc.subject | Health Economics | |
dc.subject | Health Law and Policy | |
dc.subject | Health Policy | |
dc.subject | Health Services Administration | |
dc.subject | Health Services Research | |
dc.subject | Insurance | |
dc.subject | Pharmacoeconomics and Pharmaceutical Economics | |
dc.title | Will Removing Rebates Really Lower Drug List Prices? | |
dc.type | Blog Post | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1227&context=commed_pubs&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/commed_pubs/222 | |
dc.identifier.contextkey | 13974069 | |
refterms.dateFOA | 2022-08-23T15:43:02Z | |
html.description.abstract | <p>The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for incentives to lower drug list prices, including removing rebates. Our clinical consultant Stephanie Tran continues our pharmacy blog series with an assessment of this potential change & its impacts.</p> | |
dc.identifier.submissionpath | commed_pubs/222 | |
dc.contributor.department | Commonwealth Medicine, Clinical Pharmacy Services |